Cargando…
Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia
BACKGROUND: Frequency relapses are common in Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL) following tyrosine kinase inhibitors (TKIs). CDKN2A/B is believed to contribute to this chemotherapy resistance. METHODS: To further investigate the association between CDKN...
Autores principales: | Xu, Na, Li, Yu-ling, Li, Xuan, Zhou, Xuan, Cao, Rui, Li, Huan, Li, Lin, Lu, Zi-yuan, Huang, Ji-xian, Fan, Zhi-ping, Huang, Fen, Zhou, Hong-sheng, Zhang, Song, Liu, Zhi, Zhu, Hong-qian, Liu, Qi-fa, Liu, Xiao-li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836197/ https://www.ncbi.nlm.nih.gov/pubmed/27090891 http://dx.doi.org/10.1186/s13045-016-0270-5 |
Ejemplares similares
-
CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients
por: Xu, Na, et al.
Publicado: (2015) -
Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome–positive acute lymphoblastic leukemia: a case–control study
por: Cai, Jiaoyang, et al.
Publicado: (2023) -
Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
por: Koo, Hong Hoe
Publicado: (2011) -
A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
por: Li, Lan-Zhu, et al.
Publicado: (2020) -
The Philadelphia chromosome in leukemogenesis
por: Kang, Zhi-Jie, et al.
Publicado: (2016)